Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma

7 Nov 2015

Abstract excerpt

BACKGROUND: Tumor associated macrophages are present in hepatocellular carcinoma (HCC) and associated with a poor prognosis. The aim of the present study was to investigate the levels and dynamics of soluble (s)CD163, a specific macrophage activation marker, in patients with HCC. METHODS: In a cohort from Australia, we studied 109 HCC patients, 116 patients with chronic liver disease (CLD), and 52 healthy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to Immune cells in cancer
Share to Inflammatory Biomarkers in Disease Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26549495
DOI: 10.3109/00365513.2015.1099722

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinomaPMID 26549495Read ↗

The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson's disease.Semantic proximity Read ↗

The Clinical Significance of the CD163+ and CD68+ Macrophages in Patients with Hepatocellular CarcinomaSemantic proximity Read ↗

Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitisSemantic proximity Read ↗

Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and CSemantic proximity Read ↗

Prognostic value of CD163+ macrophages in solid tumor malignancies: A scoping reviewSemantic proximity Read ↗

The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients.Semantic proximity Read ↗

The prognostic value of myeloid derived suppressor cell level in hepatocellular carcinoma: A systematic review and meta-analysis.Semantic proximity Read ↗

Tumor-derived adenosine promotes macrophage proliferation in human hepatocellular carcinoma.Semantic proximity Read ↗

Targeting of CD163+ Macrophages in Inflammatory and Malignant DiseasesSemantic proximity Read ↗

Performance of serum CD163 as a marker of fibrosis in patients with NAFLDSemantic proximity Read ↗

Soluble macrophage biomarkers indicate inflammatory phenotypes in patients with knee osteoarthritis.Semantic proximity Read ↗

Increased plasma levels of monocyte chemoattractant protein-1 in patients with hepatitis B virus pre-S2 gene deletion mutation predict a higher risk of hepatocellular carcinoma recurrence after curative surgical resection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.